Key Segmentation:
By Technology
-
Polymerase Chain Reaction (PCR) & Real-Time PCR
-
Isothermal Amplification Technologies
-
Sequencing-Based Testing
-
Hybridization-Based Assays
-
Digital Molecular Diagnostics
-
Others
By Product Type
-
Reagents & Kits
-
Instruments
-
Consumables
-
Software & Services
By Application
-
Infectious Disease Diagnostics
-
Blood Screening
-
Oncology Testing
-
Genetic Disease Testing
-
Others
By End User
-
Hospitals & Diagnostic Laboratories
-
Research & Academic Institutes
-
Blood Banks
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Others
By Sample Type
-
Blood Samples
-
Urine Samples
-
Saliva Samples
-
Tissue Samples
-
Swab Samples
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the nucleic acid testing market in 2025.
The polymerase chain reaction (PCR) & real-time PCR segment dominated the nucleic acid testing market in 2025.
Rising prevalence of infectious diseases, increasing adoption of precision medicine, expanding oncology diagnostics, and growing demand for rapid molecular testing technologies are driving demand for advanced nucleic acid testing solutions globally.
The nucleic acid testing market was valued at USD 4.52 billion in 2025.
The nucleic acid testing market is expected to grow at a CAGR of 6.57% from 2026 to 2035.